Hepion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2…

Biotechnology
US, Edison [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of HEPA's Analysis
CIK: 1583771 CUSIP: 426897104 ISIN: US4268973025 LEI: - UEI: -
Secondary Listings
HEPA has no secondary listings inside our databases.